MENU

OGEN Oragenics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OGEN is expected to report earnings to fall 95.05% to -5 cents per share on May 15

Oragenics OGEN Stock Earnings Reports
Q1'23
Est.
$-0.05
Q4'22
Beat
by $1.39
Q3'22
Beat
by $0.02
Q2'22
Beat
by $0.01
Q1'22
Missed
by $0.03
The last earnings report on February 17 showed earnings per share of -100 cents, beating the estimate of -240 cents. With 246.91K shares outstanding, the current market capitalization sits at 3.44M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

OGEN and Stocks

Correlation & Price change

A.I.dvisor tells us that OGEN and ADMA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OGEN and ADMA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-15.75%
ADMA - OGEN
28%
Poorly correlated
-4.27%
RVNC - OGEN
27%
Poorly correlated
+0.30%
PTN - OGEN
24%
Poorly correlated
-7.36%
GTBP - OGEN
22%
Poorly correlated
-1.40%
NUVL - OGEN
22%
Poorly correlated
-1.75%
More